Table 1.
Main clinical and histopathological characteristics of patients divided into training and validation sets (the percentage values are in brackets).
| Clinical Annotation | Training Set | Validation Set |
|---|---|---|
| HISTOTYPES | ||
| Clear cell | 16 (21%) | 22 (16.6%) |
| Endometroid | 19 (25%) | 55 (41.7%) |
| Mucinous | 17 (22.4%) | 21 (15.9%) |
| Serous high-grade | 16 (21.0%) | 26 (76.4%) |
| Serous low-grade | 8 (10.6%) | 8 (23.5%) |
| GRADES | ||
| G1 | 18 (23.7%) | 32 (32.6%) |
| G2 | 18 (23.7%) | 31 (31.7%) |
| G3 | 38 (50.0%) | 35 (35.7%) |
| NA | 2 (2.6%) | 0 (0%) |
| RELAPSING | ||
| No | 55 (72.4%) | 105 (79.5%) |
| Yes | 21 (27.6%) | 24 (18.2%) |
| NA | 0 (0%) | 3 (2.3%) |
| VITAL STATUS AT THE LAST FOLLOW UP | ||
| Alive | 57 (75%) | 102 (77.3%) |
| Dead of EOC | 15 (19.8%) | 9 (6.8%) |
| Dead of other cause | 2 (2.6%) | 13 (9.9%) |
| Unknown | 0 (0%) | 4 (3%) |
| Awarded | 2 (2.6%) | 4 (3%) |
| FIGO SUBSTAGE | ||
| A | 25 (32.9%) | 27 (20.5%) |
| B | 4 (5.3%) | 6 (4.5%) |
| C | 47 (61.8%) | 52 (39.4%) |
| NA | 0 (0%) | 47 (35.6%) |
| Mean age in years [min-max] | 53 [21–82] | 55 [17–80] |
| Mean follow up in years [min-max] | 9 [1–18] | 6 [0–17] |
| Total number of patients | 76 | 132 |